Skip to content

Senate’s illicit tobacco inquiry misses the lethal elephant in the room

By API User

Media release 27 November 2025 Australia’s peak body for public health is deeply concerned that the passage of the terms of reference for the Senate inquiry on illicit tobacco today missed a key question – the role of Big Tobacco and its allies.   The Public Health Association of Australia says the Senate inquiry must consider the role of the established multinational tobacco industry (Big Tobacco) and their Australian arm in;- the establishment and … Continued

Neural activity directly drives increased glioma brain cancer growth

By API User

Key points   Florey study tackles a ‘missing piece of the puzzle’ in brain cancer research by investigating the influence of cancer cells on the brain.  Characterised by their aggressiveness, different cancer grades differentially influence brain cells, with highly aggressive cancer leading to greater neural excitability.  Findings further show that this enhanced neural activity directly drives increased brain cancer growth.  This study … Continued

EXPERT ALERT: The neuroscience of Black Friday Sales

By API User

Are you being inundated with texts and emails promoting Black Friday sales? Have you purchased items you didn’t really need? What’s the neuroscience behind these marketing techniques and how can we avoid them? NeuRA’s Chief Executive Officer and Institute Director, Scientia Professor Matthew Kiernan, AM, is available to talk about: The neuroscience of Black Friday … Continued

Australia steps up to support Fiji response to HIV outbreak

By API User

Pacific Friends of Global Health has commended the Australian Government’s World AIDS Day announcement of $48 million to support Pacific HIV responses as a demonstration of Australian commitment to health security and solidarity with our near neighbours. The Pacific initiative was announced by Foreign Minister Penny Wong at the World AIDS Day Breakfast in Canberra … Continued

Experts urge more use of rapid tests to curb syphilis among pregnant women and other groups

By API User

Key points  Economic analysis shows rapid testing is cost effective and can fast-track treatment  Three testing algorithms varied in cost effectiveness and accuracy  In pregnant women, the risk of false positives is outweighed by the risk of not making tests available Researchers from Monash University and Alfred Health’s Melbourne Sexual Health Centre are advocating for … Continued

Preventable hospitalisations cost us $7.7b a year and diminish our quality of life: public health peak

By API User

Media release 27 November 2025 A new Australian Institute of Health and Welfare report has found “potentially preventable hospitalisations” were 8.5 percent of total admitted patient spending in 2023-24, and totalled $7.7b. The Cost of potentially preventable hospitalisations in Australia 2023–24 report published on 26 November classifies these into three broad categories – acute conditions, … Continued

U.S. FDA Grants Priority Review to Sonrotoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

By API User

If approved, sonrotoclax will become the first BCL2 inhibitor for R/R MCL in the U.S., addressing a high unmet need in an aggressive cancer Sonrotoclax previously received Breakthrough Therapy Designation based on clinically meaningful, rapid responses in R/R MCL BeOne Medicines will present the data supporting the NDA and Priority Review for the first time … Continued